59 related articles for article (PubMed ID: 1938761)
1. New biologic markers in non-Hodgkin's lymphomas.
Grogan TM; Miller TP
Hematol Oncol Clin North Am; 1991 Oct; 5(5):925-33. PubMed ID: 1938761
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies marking B-cell non-Hodgkin's lymphoma in paraffin-embedded tissue.
Linder J; Ye Y; Armitage JO; Weisenburger DD
Mod Pathol; 1988 Jan; 1(1):29-34. PubMed ID: 3266335
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.
Baird S
Crit Rev Clin Lab Sci; 1993; 30(1):1-28. PubMed ID: 8489735
[TBL] [Abstract][Full Text] [Related]
6. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.
Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA
Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
[TBL] [Abstract][Full Text] [Related]
9. [Non-Hodgkin's lymphoma: biologic classification, diagnosis and treatment].
Jiménez-Zepeda VH; Jiménez-Zepeda RJ
Gac Med Mex; 1998; 134(4):443-63. PubMed ID: 9789388
[TBL] [Abstract][Full Text] [Related]
10. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
11. [Recent progress in non-Hodgkin's lymphoma study in Japan].
Shimoyama M
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3169-88. PubMed ID: 2904243
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
13. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
Dzembak TM; Gurkalo VK; Gershanovich ML
Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
[TBL] [Abstract][Full Text] [Related]
14. Terminal deoxynucleotidyl transferase in diagnosis of lymphomas.
Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):245-50. PubMed ID: 2475404
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of non-Hodgkin's lymphomas.
La Via MF; Self SE
Recenti Prog Med; 1990 Oct; 81(10):629-34. PubMed ID: 2291006
[TBL] [Abstract][Full Text] [Related]
16. [Primary non-Hodgkin lymphoma of the stomach. A review with special reference to the MALT concept].
Cogliatti SB; Schmid U
Schweiz Med Wochenschr; 1994 Oct; 124(40):1764-74. PubMed ID: 7939542
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
[TBL] [Abstract][Full Text] [Related]
18. [Low grade non-Hodgkin lymphoma of B-cell type. What is the benefit of polymerase chain reaction and immunohistochemical examination?].
Aarset H; Skarsvåg S; Haugen OA
Tidsskr Nor Laegeforen; 1998 Jan; 118(3):411-4. PubMed ID: 9499731
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: regulators of growth fraction and programmed cell death.
Winter JN
Semin Oncol; 1999 Oct; 26(5 Suppl 14):26-33. PubMed ID: 10561015
[TBL] [Abstract][Full Text] [Related]
20. Application of a T cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas.
Ng CS; Chan JK; Hui PK; Chan WC; Lo ST
Am J Pathol; 1988 Aug; 132(2):365-71. PubMed ID: 2456701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
